Last mentioned: 1h ago
Target Deadline
Goal for participating nations to reach the 90-70-90 elimination milestones.
Fund Launch
Jacinda Ardern officially unveils the dedicated fund for Pacific cervical cancer elimination.
Acoziborole Rollout
The first single-dose oral cure begins deployment, enabling 'screen-and-treat' strategies.
Regional Assessment
Health audits reveal critical gaps in HPV vaccine coverage across the Pacific Islands.
WHO Global Strategy
WHO launches the global strategy to accelerate the elimination of cervical cancer.
Fexinidazole Approval
The first all-oral treatment is approved, requiring 10 days of pills taken with food.
NECT Launch
Nifurtimox-eflornithine combination therapy improves safety but requires complex intravenous administration.
Melarsoprol Introduced
Arsenic-based treatment becomes standard but carries a 5% mortality rate due to toxicity.
The introduction of acoziborole, the first single-dose oral treatment for Human African Trypanosomiasis (sleeping sickness), marks a pivotal shift in global health efforts. Developed through a non-profit partnership between DNDi and Sanofi, the drug offers a simplified path to disease elimination by 2030.
Former New Zealand Prime Minister Jacinda Ardern has launched a dedicated health fund to combat the disproportionately high rates of cervical cancer in Pacific Island nations. The initiative focuses on scaling HPV DNA testing and vaccination programs to meet WHO elimination targets by 2030.